As the impact of the global COVID-19 pandemic hits hard and fast, PharmaTimes is open for business as usual and our team remains steadfast in its aim to seek out and deliver high-quality, credible news relevant to pharma and healthcare. Stay abreast with all the latest developments across these sectors by signing up to receive our daily news alert at www.pharmatimes.com/ subscribe
This month’s issue of PharmaTimes Magazine begins with John Pinching’s comment on the UK’s handling of COVID-19, while on page 14 there’s also a special report from Ana Nicholls on the potential impact of the virus on the economy and healthcare spend.
Elsewhere, on page 20 Hilary Thomas considers the progress and challenges in reaping the benefits of genomics, while Lev Gerlovin and Pascale Diesel (p22) look at how cell and gene therapies are driving new deals in life sciences.
We also revisit the ongoing review of NICE methods and processes (p25), with Nicola Boyd asking whether the consultation will pave the way the way for health technology assessment reform.
Finally, PharmaTimes is thrilled to announce the launch of Marketer of the Year, the Sales Awards and Communications Team of the Year Awards, which are now all open for entry. Also, tickets are on sale for the International Clinical Researcher of the Year 2020 Gala dinner, which will now take place on October 2. Please visit www.pharmatimes.com/ competitions for more information.
A perfect pitch process benefits pharma as much as the agencies involved. Mike Dixon, chief executive of the Healthcare Communications Association, discusses two initiatives trying to help identify best practice guidance for all stakeholders in the pitch process